E.S. Barr & Co’s Bristol-Myers Squibb BMY Stock Holding History

E.S. Barr & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,780	Closed	-$231K	–	118
2025 Q1	$231K	Hold	3,780	–	–	0.01%	94
2024 Q4	$214K	Buy	+3,780	New	+$211K	0.01%	102
2022 Q3	–	Sell	-3,317	Closed	-$255K	–	88
2022 Q2	$255K	Sell	3,317 -1,050	-24%	-$80K	0.02%	82
2022 Q1	$319K	Hold	4,367	–	–	0.02%	85
2021 Q4	$272K	Sell	4,367 -333	-7%	-$19.5K	0.02%	89
2021 Q3	$278K	Hold	4,700	–	–	0.02%	82
2021 Q2	$314K	Buy	+4,700	New	+$306K	0.02%	80

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

E.S. Barr & Co's BMY Position: Q2 2025 in Review

E.S. Barr & Co sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,780 shares — an estimated $231K sold.

E.S. Barr & Co first reported a position in BMY in Q2 2021 and held it in 7 quarters. The position peaked at $319K in Q1 2022. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

E.S. Barr & Co reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
E.S. Barr & Co sold 3,780 Bristol-Myers Squibb shares in Q2 2025, an estimated $231K.
E.S. Barr & Co first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 7 quarters.
E.S. Barr & Co's Bristol-Myers Squibb position peaked at $319K in Q1 2022.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on E.S. Barr & Co's 13F filing for Q2 2025, filed 12 Aug 2025.